Havrix 1440, Injektionssuspension
7680005580023
CH-558
Injektionssuspension
Associated product:
HAVRIX 1440 susp inj (n ser pré) ser pré 1 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionssuspension
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
VACC
|
1440.0 U | Substance | Wirkstoff (Principe actif) |
|
VACC
|
- | Substance | WIZUS |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
0.5 MG | Substance | HNIDK |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
166.0 UG | Substance | HBESI |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
- | Substance | HBESI |
|
VACC
|
- | Substance | HNIDK |
|
VACC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 51.05
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2008
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 558
- Drug name
- Havrix 1440, Injektionssuspension
- Galenic form
- SUPA
- ATC Code
- J07BC02
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 03/09/1993
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.08.
- Domain
- Human medicine
Package details
- Description (FR)
- HAVRIX 1440 susp inj (n ser pré) ser pré 1 ml
- Description (DE)
- HAVRIX 1440 Inj Susp (n Fertspr) Fertspr 1 ml
- Market launch
- 03/09/1993
- Narcotic (BTM)
- No
Application methods
IMU
Other package sizes (2)
None
None None
GTIN: None
HAVRIX 1440 susp inj ser pré 1 ml
None None
GTIN: 7680005580054